It should be noted that blockade of IL-8 was sufficient to activate ERα transcriptional activity and that the magnitude of the activation by the combination of the anti-IL-8 antibody and E2 was far greater than the naturally saturated response of ligand (E2)-occupied ERα in low-IL-8-expressing breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.